Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Vsledek
"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomized, phase 3 trial." Lancet
101 MaierB.WendtS.VanselowJ
I know mine were for, um, the first one was for when I got small intestinal bacterial overgrowth and I, like when my IBS started, it was for that
These surgeries frequently involve patients with obesity and metabolic disease, who are most likely to be prescribed GLP-1 medications. At the studys conclusion, researchers found that use of GLP-1 and semaglutide was correlated with significantly lower chances for postoperative emergency department visits, without an increased surgical risk
